| Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit F Bert, E Maubec, B Bruneau, P Berry, N Lambert-Zechovsky Journal of Hospital infection 39 (1), 53-62, 1998 | 271 | 1998 |
| The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation N Martinez-Soria, L McKenzie, J Draper, A Ptasinska, H Issa, S Potluri, ... Cancer Cell 34 (4), 626-642. e8, 2018 | 96 | 2018 |
| Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases in a university hospital C Branger, AL Lesimple, B Bruneau, P Berry, N Lambert-Zechovsky Journal of medical microbiology 47 (3), 201-209, 1998 | 91 | 1998 |
| The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance AC Hepburn, RE Steele, R Veeratterapillay, L Wilson, EE Kounatidou, ... Oncogene 38 (22), 4412-4424, 2019 | 76 | 2019 |
| Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules J Murray, H Thomas, P Berry, S Kyle, M Patterson, C Jones, G Los, ... British journal of cancer 110 (8), 1977-1984, 2014 | 64 | 2014 |
| Epidemiological typing of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital C Branger, B Bruneau, AL Lesimple, PJM Bouvet, P Berry, J Sevali-Garcia, ... Journal of Hospital Infection 36 (1), 23-36, 1997 | 60 | 1997 |
| Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste SJ Smith, BM Tyler, T Gould, GJ Veal, N Gorelick, J Rowlinson, R Serra, ... Clinical Cancer Research 25 (16), 5094-5106, 2019 | 46 | 2019 |
| An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion, and vitamin A status in humans [S] A Oxley, P Berry, GA Taylor, J Cowell, MJ Hall, J Hesketh, G Lietz, ... Journal of Lipid Research 55 (2), 319-328, 2014 | 45 | 2014 |
| In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis O Yogev, GS Almeida, KT Barker, SL George, C Kwok, J Campbell, ... Cancer research 79 (20), 5382-5393, 2019 | 43 | 2019 |
| Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma L Chen, Y Zhao, GC Halliday, P Berry, RF Rousseau, SA Middleton, ... British journal of cancer 111 (4), 716-725, 2014 | 41 | 2014 |
| A retinol isotope dilution equation predicts both group and individual total body vitamin A stores in adults based on data from an early postdosing blood sample MH Green, JL Ford, JB Green, P Berry, AV Boddy, A Oxley, G Lietz The Journal of Nutrition 146 (10), 2137-2142, 2016 | 38 | 2016 |
| Plasma retinol kinetics and β-carotene bioefficacy are quantified by model-based compartmental analysis in healthy young adults with low vitamin A stores MH Green, JL Ford, A Oxley, JB Green, H Park, P Berry, AV Boddy, ... The Journal of Nutrition 146 (10), 2129-2136, 2016 | 32 | 2016 |
| A double-blind, randomized trial of indinavir (MK-639) alone or with zidovudine vs. zidovudine alone in zidovudine naive patients F Massari, S Stazewski, P Berry Interscience Conference on Antimicrobial Agents and Chemotherapy, California …, 1995 | 29 | 1995 |
| Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma L Chen, F Pastorino, P Berry, J Bonner, C Kirk, KM Wood, HD Thomas, ... International journal of cancer 144 (12), 3146-3159, 2019 | 27 | 2019 |
| Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial RK Jackson, M Liebich, P Berry, J Errington, J Liu, C Parker, J Moppett, ... European journal of cancer 120, 75-85, 2019 | 24 | 2019 |
| Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity E Mould, P Berry, D Jamieson, C Hill, C Cano, N Tan, S Elliott, B Durkacz, ... Biochemical pharmacology 88 (1), 58-65, 2014 | 24 | 2014 |
| Cancer-related health behaviours of young people not in education, employment or training (‘NEET’): a cross-sectional study CH Stewart, P Berry, D Przulj, C Treanor BMC cancer 17, 1-16, 2017 | 23 | 2017 |
| Two year follow-up of patients treated with indinavir 800 mg q8h D Stein, G Drusano, R Steigbigel, P Berry, J Mellors, D McMahon, ... CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS 4, 22-26, 1997 | 19 | 1997 |
| Efficacy and safety of the HIV protease inhibitor indinavir sulfate (MK639) at escalating dose RT Steigbigel, P Berry, J Mellors, D McMahon, H Teppler, D Stein, ... Third Conference on Retroviruses and Opportunistic Infections. Washington, DC 28, 1996 | 17 | 1996 |
| Liquid chromatography–mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients SA Coulthard, P Berry, S McGarrity, A Ansari, CPF Redfern Journal of Chromatography B 1028, 175-180, 2016 | 15 | 2016 |
